COVID-19 Detection Kits Market Size By product (RT-PCR Assay Kits, Immunoassay Test Strips/Cassettes), By Specimen Type (Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab), By End-use (Hospitals, Diagnostic Centers), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Industry trends

COVID-19 Detection Kits Market size exceeded USD 20.4 billion in 2020 and is poised to witness around -23.5% CAGR between 2021 and 2027. Looking at the current situation of corona virus (COVID-19) outbreak and its communicable nature, the government organizations of different countries are providing funds to ramp up production of COVID-19 detection kits. 
 

Get more details on this report - Request Free Sample PDF
 

Industry players are incorporating cutting edge innovations in custom NAAT (Nucleic Acid Amplification Tests) devices such as RT-PCR. These devices take around 3 to 4 hours to show test results. Also, several COVID-19 detection kits makers have surged the production as well as development of immunoassay test strips/cassettes to cater the market demand. However, as the large number of people are getting vaccinated in most of the countries, the new COVID-19 cases are seeing a drop, hindering the market growth.
 

Growing demand for immunoassay test strips will drive the market size

The immunoassay test strips segment garnered over 29% market share in 2020 owing to surging demand for rapid diagnostic test. These are antibody or antigen-based testing and take few minutes to show the test result.
 

The higher necessity for test strips/cassettes is also due to easy to conduct test procedure and ease in access that do not entail extremely trained authorities. However, positive results are usually precise but negative outcomes may need to be confirmed with a molecular test. Since, the test results are not fully reliable, these tests are mostly used for surveillance testing in suspected portions of population.
 

Wide availability and better results of oropharyngeal swab

Get more details on this report - Request Free Sample PDF
 

The oropharyngeal swab segment held around 27% COVID-19 detection kits market share in 2020, due to wide availability and high sensitivity of oropharyngeal swab. High number of different viral contaminations are identified in oropharyngeal swab as compared to other samples. The high yield of oropharyngeal swab is crucial for appropriate pathogen detection.
 

Presence of skilled professionals will fuel the market expansion

The diagnostic centers accounted for over USD 6.6 billion revenue in 2020, attributed to the easy availability of COVID-19 detection kits in diagnostic centers and less chances of catching hospital-acquired infection.  
 

The COVID-19 confirmatory tests require highly skilled medical professionals and advanced instruments. In addition, diagnostic centers have resources that are required to process a large batch of patient samples efficiently.
 

Strong foothold of market players in North America

Get more details on this report - Request Free Sample PDF
 

North America COVID-19 detection kits market size was over USD 4.8 billion in 2020. Regional market demand is primarily credited to strong foothold of COVID-19 detection kits manufacturers in the region along with large number of COVID-19 diseased patients. Moreover, increasing healthcare expenditure to provide better healthcare facilities and technological advancements will foster the market growth.
 

Prominent industry players are focusing on catering the higher demand for kits

Some of the notable companies operating in the market include Abbott Laboratories, BGI, BioFire Diagnostics, Cepheid, Co-Diagnostics, Randox Laboratories, F. Hoffmann-La Roche, Thermo Fisher Scientific, GenMark Diagnostics, Seegene, Guangzhou Wondfo Biotech, Mylab Discovery Solutions, Qiagen, Quidel Corporation, SD Biosensor, and Shenzhen Bioeasy Biotechnology. The manufacturers are strategically implementing various business strategies to garner larger revenue share and sustain market competition.
 

Some of the recent industry developments:

• In March 2020, Hologic received the U.S. FDA’s Emergency Use Authorization (EUA) certificate for its novel coronavirus SARS-CoV-2 molecular test. This helped the company to cater a large customer base.
   
• In March 2020, Thermo Fisher Scientific announced to gear up their RT-PCR based COVID-19 detection kits production to meet the UK’s demand for 100,000 tests per day. This helped the firm to garner a substantial market share.
   

The market research report on COVID-19 detection kits includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2020 to 2027, for the following segments:
 

Market, By Product

• RT-PCR assay kits
• Immunoassay test strips/cassettes

Market, By Specimen Type

• Nasopharyngeal swab
• Oropharyngeal swab
• Nasal swab
• Others

Market, By End-use

• Hospitals
• Diagnostic centers
• Others

The above information is provided for the following geographies:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Austria
  • Portugal
  • Sweden
  • Norway
  • Russia
  • Denmark
  • Poland
  • Switzerland
  • Turkey
  • Belgium
  • Netherlands
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Malaysia
  • Philippines
  • Indonesia
  • Thailand
  • Singapore
• Latin America
  • Brazil
  • Chile
  • Peru
  • Mexico

• Middle East
  • South Africa
  • Iran
  • Israel
  • UAE
  • Qatar
  • Iraq